MDS sells Phase II-IV operations to INC Research

Guest Contributor
July 8, 2009

MDS Inc has sold its MDS Pharma Services late stage operations to INC Research Inc, Raleigh NC, for $50 million and is continuing to seek a buyer for its Central Labs operations. The divestitures are part of the Mississauga-based firm's ongoing strategic review process. The late stage Phase II-IV operations employ 800 people in 25 countries conducting large, multi-site trials. Central Labs has 600 employees in six sites in Europe, North America and Asia. MDS is retaining its early stage operations (discovery through Phase IIa)….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.